SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
New Approach From Johns Hopkins University Promising Against Multiple Sclerosis
June 10, 2008
 · 
1 min read
Drug Development
Diabetes Drug May Slow Eye Disease, University of California, Los Angeles (UCLA) Study
June 10, 2008
 · 
1 min read
Drug Development
Price Of New Drugs May Hinder Accessibility, European Medicines Evaluation Agency Says
June 9, 2008
 · 
1 min read
Drug Development
New Hope For Rheumatoid Arthritis Sufferers: B Cells As Promising New Therapeutic Targets, University of Würzburg and University of Berlin Study
June 9, 2008
 · 
1 min read
Drug Development
Intensive Control Of Blood Sugar Does Not Reduce Heart Risk In Type 2 Diabetes, National Institutes of Health (NIH) and George Institute for International Health Study Finds
June 9, 2008
 · 
1 min read
Drug Development
‘Time-Travelling’ Bugs Resist Antibiotics Of The Future, Rutgers University Study
June 6, 2008
 · 
1 min read
Drug Development
Two-Drug Combo Reduces Diabetic Kidney Damage; Almost 25 Percent Of Participants Saw Urine Protein Levels Lowered Significantly, Study Published In New England Journal of Medicine
June 5, 2008
 · 
1 min read
Drug Development
FDA Reviews Arthritis Drugs for Links to Cancer
June 5, 2008
 · 
1 min read
Drug Development
FDA Mulls Suicide Warning for Epilepsy Drugs
June 4, 2008
 · 
1 min read
Drug Development
Antibody Drug Cost-Effective For Allergic Asthma, University of Washington and Novartis Pharma AG Study
June 4, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Kowa Pharmaceuticals America Release: New Superiority Trial Showed LIVALO® (Pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults With Dyslipidemia Versus Pravastatin 40 mg
March 7, 2013
 · 
9 min read
Drug Development
National Institute for Clinical Excellence (NICE) U-Turn on Novartis AG’s Xolair for Asthma
March 7, 2013
 · 
1 min read
Drug Development
Roche’s Rituxan Cures Rare Skin-Blistering Disease in Study
March 7, 2013
 · 
1 min read
Drug Development
Merck & Co., Inc.'s Tredaptive Raises Risk of Muscle Pain in Study
February 27, 2013
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation Release: New Findings From Two Studies Support Substantial Benefit of Pradaxa® for Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism
February 21, 2013
 · 
1 min read
Drug Development
Cumberland Pharmaceuticals Release: Caldolor® Reduces Pain and Fever in Adult Patients
February 19, 2013
 · 
4 min read
Drug Development
Bristol-Myers Squibb Company Diabetes Drug Helps Obese Adolescents Lose Weight
February 5, 2013
 · 
1 min read
Drug Development
NPS Pharmaceuticals, Inc. Release: New Peer-Reviewed Publication Offers Guidance for Integrating Gattex® (Teduglutide [rDNA origin]) for Injection into Management of Short Bowel Syndrome
January 30, 2013
 · 
1 min read
Drug Development
Pfizer Inc. Reports Positive Results in Studies of Toviaz, Pristiq, Chantix
January 24, 2013
 · 
1 min read
Drug Development
Santarus Inc. and VeroScience Announce Publication of Positive Data From Pivotal CYCLOSET® (bromocriptine mesylate) Efficacy Study
January 23, 2013
 · 
1 min read
Drug Development
Novartis AG Says Afinitor Reduces Tumors in Rare Genetic Disease
January 11, 2013
 · 
16 min read
Drug Development
Merck & Co., Inc.'s Tredaptive is Under Review by European Medicines Agency After Failed Trial
December 21, 2012
 · 
1 min read
Drug Development
Merck & Co., Inc. Cholesterol Drug Fails; Risks Seen
December 20, 2012
 · 
4 min read
Drug Development
Immune Response BioPharma Files for Orphan Designation of REMUNE for Pediatric HIV/AIDS
December 17, 2012
 · 
3 min read
Drug Development
Pfizer Inc.'s Chantix Produced More Heart Concerns, FDA Says
December 13, 2012
 · 
1 min read
Drug Development
Celgene Release: REVLIMID® and VIDAZA® Combination Therapy Achieves Nearly 30 Percent Complete Response in Untreated Elderly Patients With Acute Myeloid Leukemia
December 11, 2012
 · 
1 min read
Drug Development
Celgene International Sárl Release: Analysis of Post-Progression Outcomes in MM-015 Study Presented at the 54th American Society of Hematology Annual Meeting
December 11, 2012
 · 
1 min read
Drug Development
Novo Nordisk A/S Bets on Turning Victoza Into Obesity Blockbuster
December 11, 2012
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation Release: Treatment With Pradaxa® Associated With Better Patient Outcomes After a Major Bleeding Event Compared to Warfarin
December 10, 2012
 · 
1 min read
Drug Development
Genentech’s Perjeta Extends Life of Breast Cancer Patients by 34 Pct
December 10, 2012
 · 
7 min read
Load More